The Trans Pacific Partnership (TPP) trade package is beginning to unravel, with more prominent voices slamming President Obama and the republican leadership over the secretive deal that threatens to cost American jobs and hand big corporations new powers that would violate national sovereignty.
Critics of the TPP assert the trade deal will give huge corporations the power to change U.S. laws.
Physicians are rallying as they become increasingly concerned about the passage of TPP. Prescription drug costs could waylay the affordability of biologics and thousands of prescription drugs by drastically altering intellectual property protections. Under the TPP, corporations could sue countries for restricting their products due to legislation brought to fruition by government policies. The Investor State Dispute Settlement portion of the TPP gives the upper hand to the corporatocracy. Legislative bodies would only act as advisory boards to the ruling governments.